Abstract
1 In 580 hypertensive patients treated with guanfacine for one year and 169 patients who continued the treatment for a second year, laboratory measurements were made before, during and after the end of treatment. Side-effects were registered every month. On completion of the one and two-year studies respectively, therapy was discontinued and blood pressure, heart rate and side-effects were recorded in order to assess the frequency of a withdrawal syndrome.